European Human Epigenome Project Yields Promising Results for PGx, Dx Researchers | GenomeWeb
A recently published study has found that epigenomic markers produce a better signal-to-noise ratio than some researchers had believed, a discovery that could help convince hesitant diagnostics researchers to investigate the epigenomics space.
The findings, derived from the first major data release of the Human Epigenome Project, could also take epigenomic markers one step closer to becoming components in pharmacogenomics applications.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.